Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Ma-Spore ALL 2020 Study
- Status
- RECRUITING
- Phase
- PHASE2
CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Study on the Efficacy and Safety of Low-dose CTX as Maintenance Therapy for MM Unsuitable for Transplantation
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Allogeneic TRAC Locus-inserted CD19-targeting STAR T Cell Therapy in r/r B-NHL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of Care in Adults With Relapsed or Refractory Follicular Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE3
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Status
- RECRUITING
- Phase
- PHASE1
Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
- Status
- RECRUITING
- Phase
- PHASE1
Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5
- Status
- RECRUITING
- Phase
- PHASE3
AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase Ib Study of Rocbrutinib in Combination with R-CHOP in Patients with Newly Diagnosed B-cell Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC
- Status
- RECRUITING
- Phase
- PHASE2